The Chris Wolfe Podcast: The Dark Side of Glaucoma Meds: New Guidance on Ocular Surface Damage

episode

EyeCode Media not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from EyeCode Media

The Chris Wolfe Podcast:Your AMD Technology Isn’t the Problem—Your System Is 20 min · 21 Sep 2026

AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health 54 min · 17 Sep 2026

The Chris Wolfe Podcast: The Power of Quality Supplements 48 min · 14 Sep 2026

The Chris Wolfe Podcast: All Things Caratenoids w/ Kirsten Ormsby 56 min · 18 May 2026

All episodes from EyeCode Media →

Report any issue

Source

Recorded24 Feb 2025

Publisherfeed.podbean.com ↗

Handlerec:9097877

Show notes

This podcast episode discusses the impact of anti-glaucoma medications on ocular surface health, referencing the latest evidence-based guidelines from the American Optometric Association. It emphasizes the importance of understanding the relationship between glaucoma treatments and ocular surface disease, and the role of optometrists in managing these patients effectively. https://www.aoa.org/practice/clinical-guidelines/clinical-practice-guidelines?sso=y ---------------------- For our listeners, use the code 'EYECODEMEDIA22' for 10% off at check out for our Premiere Billing & Coding bundle or our EyeCode Billing & Coding course. Sharpen your billing and coding skills today and leave no money on the table! [email protected] https://coopervision.com/our-company/news-center/press-release/coopervision-and-aoa-join-forces-launch-myopia-collective Go to MacuHealth.com and use the coupon code PODCAST2024 at checkout for special discounts Show Sponsors: CooperVision MacuHealth EssilorLuxottica

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.